ASH 2024: AstraZeneca set to take a BiTE out of follicular lymphoma market

Submitted by admin on December 9, 2024 - 11:12am

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

GlobalData’s analysts predict $158 million in global sales for AZD0486 by 2030, with $2.4 billion for Epkinly and $949 million for Lunsumio.

Search form